Trial Profile
A Single Center, Open-label Trial of Isavuconazole Prophylaxis Against Invasive Fungal Infection in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HCT)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Nov 2021
Price :
$35
*
At a glance
- Drugs Isavuconazole (Primary) ; Isavuconazole (Primary) ; Micafungin
- Indications Mycoses
- Focus Therapeutic Use
- 15 Nov 2021 Status changed from active, no longer recruiting to completed.
- 09 Aug 2021 Planned End Date changed from 1 May 2021 to 1 May 2022.
- 03 Jun 2020 Planned End Date changed from 1 May 2020 to 1 May 2021.